Luisa Mori

934 total citations
22 papers, 570 citations indexed

About

Luisa Mori is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Luisa Mori has authored 22 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 10 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Luisa Mori's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (6 papers) and Immune Cell Function and Interaction (4 papers). Luisa Mori is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (6 papers) and Immune Cell Function and Interaction (4 papers). Luisa Mori collaborates with scholars based in United States, United Kingdom and Italy. Luisa Mori's co-authors include Sabrina Mattoli, Martin Stacey, M. Schmidt, Susana T. Valente, Claudia Mauri, Chuan Li, Cong‐Qiu Chu, Marco Londei, D F Woodrow and A. Bellini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Luisa Mori

19 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisa Mori United States	10	145	128	116	111	97	22	570
Asim Ejaz United States	16	168 1.2×	138 1.1×	24 0.2×	35 0.3×	58 0.6×	43	740
R. Bauer Germany	16	77 0.5×	216 1.7×	47 0.4×	33 0.3×	20 0.2×	49	722
Oumaima Stambouli Germany	10	435 3.0×	101 0.8×	26 0.2×	73 0.7×	16 0.2×	11	719
B.‐L. Hsi France	14	135 0.9×	256 2.0×	42 0.4×	74 0.7×	15 0.2×	28	783
Guillermo Palao Spain	8	181 1.2×	136 1.1×	18 0.2×	54 0.5×	23 0.2×	10	469
Claudia Dechant Germany	17	130 0.9×	584 4.6×	43 0.4×	50 0.5×	9 0.1×	40	1.3k
Kirsten A. Keyser United States	12	251 1.7×	157 1.2×	16 0.1×	31 0.3×	14 0.1×	18	630
Patrick T. Coates Australia	16	197 1.4×	475 3.7×	23 0.2×	29 0.3×	22 0.2×	39	1.1k
Jean-Marie Bonnetblanc France	19	102 0.7×	67 0.5×	16 0.1×	59 0.5×	19 0.2×	65	1.2k
Xavier Lafarge France	14	71 0.5×	602 4.7×	20 0.2×	50 0.5×	17 0.2×	43	1.0k

Countries citing papers authored by Luisa Mori

Since Specialization

Citations

This map shows the geographic impact of Luisa Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Mori more than expected).

Fields of papers citing papers by Luisa Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Mori. The network helps show where Luisa Mori may publish in the future.

Co-authorship network of co-authors of Luisa Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Mori. A scholar is included among the top collaborators of Luisa Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Mori. Luisa Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ling, Lijun, Luisa Mori, Wenbo Yao, et al.. (2025). Combining spironolactone to antiretroviral therapy accelerates HIV decay in humanized mice. Emerging Microbes & Infections. 14(1). 2589549–2589549.

Gibaut, Quentin M. R., et al.. (2025). FUBP3 enhances HIV-1 transcriptional activity and regulates immune response pathways in T cells. Molecular Therapy — Nucleic Acids. 36(2). 102525–102525.

Goel, Viraat Y., Luisa Mori, Leonid A. Mirny, et al.. (2025). Dynamics of microcompartment formation at the mitosis-to-G1 transition. Nature Structural & Molecular Biology. 32(12). 2614–2627.

Gibaut, Quentin M. R., Luisa Mori, & Susana T. Valente. (2023). HIV-1 transcriptional modulation: novel host factors and prospective therapeutic strategies. Current Opinion in HIV and AIDS. 18(5). 264–272. 5 indexed citations

Mori, Luisa, et al.. (2022). OP 1.5 – 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment. Journal of Virus Eradication. 8. 100100–100100. 1 indexed citations

Mori, Luisa & Susana T. Valente. (2022). Cure and Long-Term Remission Strategies. Methods in molecular biology. 2407. 391–428. 9 indexed citations

Salvador, Felipe Scassi, et al.. (2020). Use of molecular tools for the diagnosis of rangeliosis by Rangelia vitalii in Argentina: A case report. Veterinary Parasitology Regional Studies and Reports. 21. 100426–100426. 2 indexed citations

Mori, Luisa & Susana T. Valente. (2020). Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure. Viruses. 12(5). 529–529. 34 indexed citations

Li, Chuan, Luisa Mori, & Susana T. Valente. (2020). The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro–Cortistatin A. The Journal of Infectious Diseases. 223(Supplement_1). S46–S53. 28 indexed citations

10.

Mori, Luisa, Katharine M. Jenike, Yang-Hui Jimmy Yeh, et al.. (2020). The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription, and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency. Journal of Virology. 95(4). 15 indexed citations

11.

Takata, Hiroshi, Cari F. Kessing, Noemia S. Lima, et al.. (2019). Modeling HIV-1 Latency Using Primary CD4⁺T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy. Journal of Virology. 93(11). 11 indexed citations

12.

Adland, Emily, Luisa Mori, Anna Csala, et al.. (2018). Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia. AIDS. 32(11). 1413–1422. 5 indexed citations

13.

Mori, Masahiko, Emily Adland, P Paioni, et al.. (2015). Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection. PLoS ONE. 10(7). e0131591–e0131591. 18 indexed citations

14.

Mori, Luisa, et al.. (2004). Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Experimental Cell Research. 304(1). 81–90. 300 indexed citations

15.

Mauri, Claudia, Cong‐Qiu Chu, D F Woodrow, Luisa Mori, & Marco Londei. (1997). Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. The Journal of Immunology. 159(10). 5032–5041. 52 indexed citations

16.

Mauri, Claudia, Cong‐Qiu Chu, D Woodrow, Luisa Mori, & Marco Londei. (1997). Treatment of newly established transgenic model of chronic relapsing arthritis with non-depleting anti CD4 monocional antibody. Immunology Letters. 56. 372–372. 4 indexed citations

17.

Mori, Luisa, et al.. (1995). Bronchial Epithelial Cells of Atopic Patients with Asthma Lack the Ability to Inactivate Allergens. Biochemical and Biophysical Research Communications. 217(3). 817–824. 23 indexed citations

18.

Cattaneo, E., Davide Zella, Andrea Cimarelli, et al.. (1992). Concordance of HIV culture and PCR analysis in the diagnosis of vertically transmitted infection. 3(4). 183–186. 4 indexed citations

19.

Mori, Luisa, et al.. (1990). [Dilated cardiomyopathy and visceral anomalies in myotonic dystrophy].. PubMed. 38(5). 231–4. 1 indexed citations

20.

Righi, Marco, et al.. (1989). Generation of new oncogenic murine retroviruses by cotransfection of cloned AKR and MH2 proviruses.. PubMed. 4(2). 223–30. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact